Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy

Medical Care

Volumn 37, Issue 9, 1999, Pages 846-857

  Choo, Peter W ^a,e   Rańd, Cynthia S ^d   Inui, Thomas S ^b   Lee, Mei Ling T ^a,c   Cain, Emily ^b   Cordeiro Breault, Michelle ^b   Canning, Claire ^b   Platt, Richard ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

^e NONE   (United States)

Author keywords

Adherence; Antihypertensive therapy; Automated pharmacy records; Electronic adherence monitoring; Measurement validation; Pill counts

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ADULT; AGED; AMBULATORY MONITORING; ANALYSIS OF VARIANCE; ARTICLE; DRUG ADMINISTRATION; DRUG MONITORING; FEMALE; HEALTH INSURANCE; HUMAN; MALE; MEDICAL INFORMATION SYSTEM; MEDICAL RECORD; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT COMPLIANCE; PRESCRIPTION; QUESTIONNAIRE; REPRODUCIBILITY; STATISTICS; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BOSTON; CLINICAL PHARMACY INFORMATION SYSTEMS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MONITORING, AMBULATORY; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0033194758     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199909000-00002     Document Type: Article

References (48)

1. Gordis L. Conceptual and methodologic problems in measuring patient compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: The Johns Hopkins University Press, 1979:23-45.
2. Fletcher SW, Pappius EM, Harper SJ. Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. Arch Intern Med 1979;139:635-8.
3. Rudd P. In search of the gold standard for compliance measurement. Arch Intern Med 1979;139: 627-8.
4. Rudd P, Marshall G. Resolving problems of measuring compliance with medication monitors. J Compliance Health Care 1987;2:23-35.
5. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, Ltd., 1991:3-10.
6. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994;149(suppl):S69-76.
7. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993;72:68D-74D.
8. Charney E, Bynum R, Eldridge D, et al. How well do patients take oral penicillin? A collaborative study in private practice. Pediatrics 1967;40:188-95.
9. Mushlin AI, Appel FA. Diagnosing potential noncompliance: Physicians' ability in a behavioral dimension of medical care. Arch Intern Med 1977;137:318-21.
10. Caron HS, Roth HP. Patients' cooperation with a medical regimen, difficulties in identifying the noncooperator. JAMA 1968;203:120-4.
11. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986; 524:524-30.
12. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Med Care 1988;26:814-23.
13. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
14. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: Is self-report the best available measure? Med Care 1981;19:1061-4.
15. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
16. Norell SE, Granstrom PA. Self medication with pilocarpine among outpatients in glaucoma clinic. Br J Ophthalmol 1980;64:137-41.
17. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515-23.
18. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-7.
19. Cramer JA, Ouellette VL, Mattson RH. How can medication noncompliance be measured? Epilepsia. 1988;29:705A.
20. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Improved compliance measures: Applications in an ambulatory hypertension drug trial. Clin Pharmcol Ther 1990;48:676-85.
21. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Antihypertensive drug trials: Contributions from medication monitors. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, Ltd., 1991:283-99.
22. Olivieri NF, Matsui D, Hermann C, Koren G. Compliance assessed by the medication event monitoring system. Arch Dis Child 1991;66:1399-1402.
23. Kruse W, Weber E. Dynamics of drug regimen compliance - its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990;38:561-6.
24. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E. Dosage frequency and drug compliance behaviour - a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991;41:589-92.
25. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed frequency of daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4.
26. Eisen SA, Woodward RS, Miller DK, . Spitznagel E, Windham CA. The effect of medication compliance on the control of hypertension. J Gen Intern Med 1987;2:298-305.
27. Eisen SA. Developing more clinically meaningful definitions of medication compliance. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, Ltd., 1991:225-31.
28. Tashkin DP, Rand CS, Nides M, et al. A nebulizer chronolog to monitor compliance with inhaler use. Am J Med 1991;91(suppl 4A):33S-6S.
29. Urquhart J. Patient compliance with prescribed drug regimens: Overview of the past 30 years of research. In: Nimmo WS, Tucker GT, eds. Clinical Measurement in Drug Evaluation. Chichester (UK): John Wiley & Sons, Ltd., 1995:213-27.
30. Barnett GO, Justice NS, Somand ME, et al. COSTAR: A computer based medical information system for ambulatory care. Proc Inst Electrical Electronics Eng. 1979;67:1226-37.
31. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997;35:1164-70.
32. Hirschhorn LR, Trnka Y, Onderdonk A, Lee M-LT, Platt R. Epidemiology of community acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994;169:127-33.
33. Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-83.
34. nd Ed. Boston: PWS-Kent Publishing Co., 1988.
35. Krall RL. Interaction of compliance and patient safety. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, Ltd., 1991:19.
36. Horowitz RI, Horowitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993;153:1863-8.
37. Stanaway L, Lambie DG, Johnson RH. Non-compliance with anticonvulsant therapy as a cause of seizures. N Z Med J 1985;98:150-2.
38. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Arch Intern Med 1988;148:2013-6.
39. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Noncompliance in organ transplant recipients. Transplant Proc 1989;21:833-4.
40. Maronde RF, Chan LS, Larsen FJ, Strandberg LR, Laventurier MF, Sullivan SR. Underutilization of antihypertensive drugs and associated hospitalization. Med Care 1989;27:1159-66.
41. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA 1990;263:1653-7.
42. Kruse W. Compliance with treatment of hyperlipoproteinemia in medical practice and clinical trials. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, Ltd., 1991:175-86.
43. Taylor D, Sackett D, Haynes R, Johnson A, Gibson E, Roberts R. Compliance with antihypertensive drug therapy. Ann NY Acad Sci 1978;304:390-403.
44. Steiner JF, Fihn SD, Blair B, Inui TS. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol 1991;44:1361-71.
45. Browner WS, Newman TB, Cummings SR. Designing a new study: III. Diagnostic tests. In: Hulley SB, Cummings SR, eds. Designing Clinical Research. Baltimore: Williams and Wilkins, 1988:87-97.
46. Hennekens CH, Buring JE. Intervention studies. In: Mayrent SL, ed. Epidemiology in medicine. Boston: Little, Brown and Co., 1987:178-212.
47. Curtin RB, Svarstad BL, Andress D, Keller T, Sacksteder P. Differences in older versus younger hemodialysis patients' compliance with oral medications. Geriatr Nephrol Urol 1997;7:35-44.
48. Stephenson BJ, Rowe BH, Haynes B, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA 1993;269:2779-81.